Stephen M. Hobbs
- Co-authors
- John C. WallaceSarawut JitrapakdeeJane PeppardKatharine PestellMichael I. WaltonJenny TitleyLloyd R. KèllandShiuan Chen
- Topics
- Monoclonal and Polyclonal Antibodies Research (6 papers)Toxin Mechanisms and Immunotoxins (2 papers)Glycosylation and Glycoproteins Research (2 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
- Journals
- Biochemical and Biophysical Research CommunicationsJournal of Medicinal ChemistryEuropean Journal of Immunology
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Stephen M. Hobbs
13 papers receiving 608 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 398
- Oncology 160
- Immunology 90
- Cancer Research 73
- Toxicology 69
Countries citing papers authored by Stephen M. Hobbs
This map shows the geographic impact of Stephen M. Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen M. Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen M. Hobbs more than expected).
Fields of papers citing papers by Stephen M. Hobbs
This network shows the impact of papers produced by Stephen M. Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen M. Hobbs. The network helps show where Stephen M. Hobbs may publish in the future.
Co-authorship network of co-authors of Stephen M. Hobbs
This figure shows the co-authorship network connecting the top 25 collaborators of Stephen M. Hobbs. A scholar is included among the top collaborators of Stephen M. Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen M. Hobbs. Stephen M. Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin. | 44 |
| 3 | 5 | |
| 4 | 95 | |
| 5 | Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. | 89 |
| 6 | 40 | |
| 7 | 237 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 8 | |
| 11 | 13 | |
| 12 | 34 | |
| 13 | 66 |
About Stephen M. Hobbs
Stephen M. Hobbs is a scholar working on Toxicology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 13 papers that have together received 653 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Toxicology (69 citations), Oncology (160 citations) and Molecular Biology (398 citations). Stephen M. Hobbs has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John C. Wallace, Sarawut Jitrapakdee, Jane Peppard, Katharine Pestell, Michael I. Walton, Jenny Titley, Lloyd R. Kèlland, Shiuan Chen, Richard J. Knox and Terence C. Jenkins. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.